Skip to main content
White paper

Part D redesign under the Inflation Reduction Act

Potential financial ramifications for Part D plans and pharmaceutical manufacturers

By Corey Nathan Berger, Tyler Engel, and Todd M. Wanta
30 August 2023

About the Author(s)

Corey Nathan Berger

Atlanta Tel: 1 404 2377060

View bio

Tyler Engel

New York Tel: 1 646 4733363

View bio

Todd M. Wanta

Milwaukee Tel: 1 262 7842250

View bio

We’re here to help

Ask the tough questions. We’re ready for them.

popup image